AlphaYouOA
Schedule 13D filing
ORBIMED ADVISORS LLC disclosed a 5.8% stake in ArriVent BioPharma, Inc. (AVBP)
ORBIMED ADVISORS LLC reported owning 5.8% of ArriVent BioPharma, Inc. (AVBP) (2,875,962 shares) in a Schedule 13D filed Oct 8, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 8, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.